CPMV (Mosaic ImmunoEngineering) EBIT per Share : $-0.14 (TTM As of Sep. 2024)

View and export this data going back to . Start your Free Trial

What is Mosaic ImmunoEngineering EBIT per Share?

Mosaic ImmunoEngineering's EBIT per Share for the three months ended in Sep. 2024 was $-0.02. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.14.

During the past 3 years, the average EBIT per Share Growth Rate was 46.40% per year. During the past 5 years, the average EBIT per Share Growth Rate was 31.50% per year. During the past 10 years, the average EBIT per Share Growth Rate was 18.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Mosaic ImmunoEngineering's EBIT per Share or its related term are showing as below:

CPMV' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -42.2 Med: 16.3 Max: 50.8
Current: 46.4

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Mosaic ImmunoEngineering was 50.80% per year. The lowest was -42.20% per year. And the median was 16.30% per year.

CPMV's 3-Year EBIT Growth Rate is ranked better than
91.45% of 1228 companies
in the Biotechnology industry
Industry Median: 5.9 vs CPMV: 46.40

Mosaic ImmunoEngineering's EBIT for the three months ended in Sep. 2024 was $-0.17 Mil.

Mosaic ImmunoEngineering EBIT per Share Historical Data

The historical data trend for Mosaic ImmunoEngineering's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mosaic ImmunoEngineering EBIT per Share Chart

Mosaic ImmunoEngineering Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-0.92

-1.25

-0.53

-0.31

-0.13

Mosaic ImmunoEngineering Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT per Share	Get a 7-Day Free Trial															-0.04	-0.04	-0.04	-0.04	-0.02

Mosaic ImmunoEngineering EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Mosaic ImmunoEngineering's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.917	/	7.236
=	-0.13

Mosaic ImmunoEngineering's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

	EBIT per Share		(Q: Sep. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.165	/	7.236
=	-0.02

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.14

Mosaic ImmunoEngineering (OTCPK:CPMV) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Mosaic ImmunoEngineering EBIT per Share Related Terms

Thank you for viewing the detailed overview of Mosaic ImmunoEngineering's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Mosaic ImmunoEngineering Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mosaic ImmunoEngineering Inc (OTCPK:CPMV) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

9114 Adams Avenue, Suite 202, Huntington Beach, CA, USA, 92646

Website

https://www.mosaicie.com

Mosaic ImmunoEngineering Inc is a development-stage biotechnology company focused on bridging immunology and engineering to develop novel immunotherapies to treat and prevent cancer and infectious diseases. It has a single operating segment for the purposes of assessing performance and making operating decisions.

Executives

Robert Baffi	director	C/O BIOMARIN PHARMACEUTICAL INC., 105 DIGITAL DRIVE, NOVATO CA 94949
Case Western Reserve University	10 percent owner	10900 EUCLID AVENUE, CLEVELAND OH 44106
Steven W King	director, officer: President and CEO
Paul J Lytle	director, officer: EVP, Chief Financial Officer
Robert L Garnick	director	C/O PATRIOT SCIENTIFIC, 2038 CORTE DEL NOGAL, SUITE 141, CARLSBAD CA 92011
Nicole Franziska Steinmetz	director, officer: Chief Scientific Officer	871 WILBUR AVENUE, SAN DIEGO CA 92019
Dharmesh Mistry	director	315 PEMBROKE COURT, SAN RAMON CA 94582
Carlton M Johnson	director
Donald E Schrock	director	C/O INTEGRATED DEVICE TECHNOLOGY, INC., 6024 SILVER CREEK VALLEY ROAD, SAN JOSE CA 95138
Paul R Bibeau	officer: VP, Business Development	MICROSEMI CORP, 2381 MORSE AVE, IRVINE CA 92614
Frederick C Goerner	officer: Chief Executive Officer	MICROSEMI CORPORATION, ONE ENTERPRISE, ALISO VIEJO CA 92656
Clifford L Flowers	officer: Chief Financial Officer	C/O BAKBONE SOFTWARE, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO CA 92121
Harry L Tredennick	director	6183 PASEO DEL NORTE #180, CARLSBAD CA 92011
Thomas J Sweeney	officer: CFO
Helmut Jr Falk	director